Chardan Slaps “Buy” Rating on CAMP4 Therapeutics – $6.50 Price Target Signals 60%+ Upside
Its new gene-boosting drug shows promise for rare brain disorders with no treatments yet.
NOTRELOAD AI
Robinhood Just Got Approved as an IPO Underwriter — Here’s Why It’s a Game-Changer for Retail Investors
CEO Vlad Tenev says the move will disrupt Wall Street and give retail investors bigger access to hot IPOs like SpaceX.
B. Riley Sees Multi-Billion Dollar Potential in Elicio’s mKRAS Vaccine
B. Riley sees Elicio as a strong Buy; mKRAS cancer vaccine data in June could be a major stock catalyst.
Clover Health Triumphs in Court – Massive 4.5-Star Medicare Rating Upgrade
Clover Health got its Medicare rating raised to 4.5 stars, boosting future government bonus payments from 2027.
Amazon Just Opened Its Freight Network to Every Business — LTL Stocks Are Tanking
Amazon expands its freight service to all US businesses, hitting rivals like Old Dominion as shares fall on competition fears.
Barclays Predicts Oscar Health Will Benefit Most from ACA Boom
Barclays raised Oscar Health rating, sees higher price target as ACA growth and pricing gains boost future profits.